home / stock / sva:cc / sva:cc articles
No one has written and article on Sernova Corp., stock symbol SVA:CC. Be the first to contribute and write an article.
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...
Mission Ready Solutions Inc. (MRS.H:CA) is expected to report for Q1 2024 Imperial Ginseng Products Ltd. (IGP:CA) is expected to report for Q3 2024 PreveCeutical Medical Inc. (PREV:CNX) is expected to report for Q1 2024 Select Sands Corp. (SNS:CA) is expected to report for Q1 2024 ...